Yang Lü
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Drug Discovery top 5%
Papers in
-
- Crystallography and molecular interactions 47
-
- Natural product bioactivities and synthesis 24
- Bioactive Natural Diterpenoids Research 23
- Co-authors
- Guanhua Du (71 shared papers)Qi‐Tai Zheng (44 shared papers)Han‐Dong Sun (27 shared papers)Dezhi Yang (48 shared papers)Shiying Yang (39 shared papers)Ningbo Gong (46 shared papers)Li Zhang (40 shared papers)Xiao‐Jiang Hao (20 shared papers)
- Journals
- Journal of Natural Products (26 papers)Organic Letters (12 papers)Tetrahedron Letters (10 papers)Natural Products and Bioprospecting (9 papers)Helvetica Chimica Acta (9 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yang Lü
261 papers receiving 8.2k citations
Yang Lü's Hit Papers
Peers
Comparison fields: 5 of 159
- Infectious Diseases 2.3k
- Drug Discovery 13
- Physical and Theoretical Chemistry 471
- Complementary and alternative medicine 312
- Organic Chemistry 1.1k
Countries citing papers authored by Yang Lü
This map shows the geographic impact of Yang Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Lü more than expected).
Fields of papers citing papers by Yang Lü
This network shows the impact of papers produced by Yang Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Lü. The network helps show where Yang Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 273 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Hit paper breakdown → | 2020 | 2735 |
| 2 | 2020 | 230 | |
| 3 | 2020 | 140 | |
| 4 | 2004 | 132 | |
| 5 | 2011 | 91 | |
| 6 | 2008 | 90 | |
| 7 | 2021 | 89 | |
| 8 | 2003 | 83 | |
| 9 | 2004 | 83 | |
| 10 | 2007 | 80 | |
| 11 | 2005 | 77 | |
| 12 | 2019 | 76 | |
| 13 | 2007 | 67 | |
| 14 | 2020 | 66 | |
| 15 | 2021 | 65 | |
| 16 | 2014 | 64 | |
| 17 | 2008 | 62 | |
| 18 | 2017 | 62 | |
| 19 | 2008 | 59 | |
| 20 | 2006 | 58 |
About Yang Lü
Yang Lü is a scholar working on Physical and Theoretical Chemistry, Molecular Biology, Complementary and alternative medicine, Materials Chemistry and Plant Science, having authored 273 papers that have together received 8.5k indexed citations. Recurring topics across this work include Crystallography and molecular interactions (47 papers), Crystallization and Solubility Studies (46 papers), Phytochemistry and Biological Activities (26 papers), Natural product bioactivities and synthesis (24 papers), Bioactive Natural Diterpenoids Research (23 papers), Traditional Chinese Medicine Analysis (17 papers), Crystal structures of chemical compounds (15 papers) and Drug Solubulity and Delivery Systems (12 papers). The work is most often cited by research in Infectious Diseases (2.3k citations), Drug Discovery (13 citations), Physical and Theoretical Chemistry (471 citations), Complementary and alternative medicine (312 citations) and Organic Chemistry (1.1k citations). Yang Lü has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Guanhua Du, Qi‐Tai Zheng, Han‐Dong Sun, Dezhi Yang, Shiying Yang, Ningbo Gong, Li Zhang, Xiao‐Jiang Hao, Wei‐Lie Xiao and Jian‐Xin Pu. Their work appears in journals such as Journal of Natural Products, Organic Letters, Tetrahedron Letters, Natural Products and Bioprospecting and Helvetica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.